Stockscreener 앱 받기
35.16
12.86%
4.0126
전일 마감가:
$31.15
열려 있는:
$31.61
하루 거래량:
2.15M
Relative Volume:
0.61
시가총액:
$4.90B
수익:
$264.79M
순이익/손실:
$-14.36M
주가수익비율:
-125.58
EPS:
-0.28
순현금흐름:
$67.82M
1주 성능:
+13.98%
1개월 성능:
+44.26%
6개월 성능:
+111.79%
1년 성능:
+185.36%
1일 변동 폭
$31.36
$35.20
1주일 범위
$28.59
$35.03
52주 변동 폭
$12.26
$36.50
TG테라퓨틱스사 Stock (TGTX) Company Profile
명칭
Tg Therapeutics Inc
전화
(212) 554-4484
주소
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| TGTX | 35.14 | 4.90B | 264.79M | -14.36M | 67.82M | -0.28 |
| VRTX | 447.30 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 745.59 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.15 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.57 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 104.51 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
TG테라퓨틱스사 Stock (TGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-02 | 업그레이드 | Goldman | Sell → Neutral |
| 2023-06-26 | 재개 | Jefferies | Buy |
| 2022-05-20 | 개시 | BofA Securities | Underperform |
| 2022-02-23 | 재확인 | B. Riley Securities | Buy |
| 2021-11-15 | 다운그레이드 | Goldman | Neutral → Sell |
| 2021-04-20 | 개시 | Goldman | Neutral |
| 2021-04-19 | 재확인 | H.C. Wainwright | Buy |
| 2020-09-01 | 개시 | JP Morgan | Overweight |
| 2020-08-11 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-05 | 개시 | Evercore ISI | Outperform |
| 2020-01-17 | 재확인 | H.C. Wainwright | Buy |
| 2019-11-27 | 재개 | B. Riley FBR | Buy |
| 2019-02-06 | 재개 | Jefferies | Buy |
| 2018-09-25 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 재개 | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 재개 | H.C. Wainwright | Buy |
| 2017-04-25 | 개시 | Jefferies | Buy |
| 2017-03-06 | 재확인 | FBR & Co. | Outperform |
| 2016-10-06 | 재개 | Brean Capital | Buy |
| 2016-05-27 | 개시 | SunTrust | Buy |
| 2015-12-01 | 개시 | FBR Capital | Outperform |
| 2015-09-09 | 개시 | Raymond James | Strong Buy |
| 2015-08-12 | 재개 | H.C. Wainwright | Buy |
| 2015-06-19 | 재확인 | Brean Capital | Buy |
| 2014-12-11 | 재확인 | ROTH Capital | Buy |
| 2014-12-10 | 재확인 | ROTH Capital | Buy |
모두보기
TG테라퓨틱스사 주식(TGTX)의 최신 뉴스
TG Therapeutics Claims #1 Spot on Deloitte Fast 500 List, Driven by MS Drug Success | TGTX Stock News - StockTitan
TG Therapeutics Ranked Number One Fastest-Growing Company - GlobeNewswire
TG Therapeutics Ranked Number One Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™ - Yahoo Finance
Oppenheimer & Co. Inc. Acquires New Shares in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
State of New Jersey Common Pension Fund D Decreases Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
When (TGTX) Moves Investors should Listen - Stock Traders Daily
Entropy Technologies LP Purchases Shares of 31,200 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Amalgamated Bank - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Acquired by Los Angeles Capital Management LLC - MarketBeat
Insider Sale: Director Laurence Charney Sells 25,000 Shares of T - GuruFocus.com
Insider Sale: Director Sagar Lonial Sells 5,000 Shares of TG The - GuruFocus.com
New York State Teachers Retirement System Invests $1 Million in TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
Don't Ignore The Insider Selling In TG Therapeutics - Simply Wall St
TG Therapeutics stock hits 52-week high at $28.43 - Investing.com India
TG Therapeutics stock hits 52-week high at $28.43 By Investing.com - Investing.com Canada
FY2024 EPS Estimates for TG Therapeutics Raised by Analyst - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Sets New 1-Year HighWhat's Next? - MarketBeat
FY2027 EPS Forecast for TG Therapeutics Decreased by Analyst - MarketBeat
Optimistic Investors Push TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Up 27% But Growth Is Lacking - Simply Wall St
TG Therapeutics, Inc. Just Missed EarningsBut Analysts Have Updated Their Models - Yahoo Finance
FY2024 EPS Estimates for TG Therapeutics Lowered by Analyst - MarketBeat
HC Wainwright Boosts Earnings Estimates for TG Therapeutics - MarketBeat
TG Therapeutics Inc (TGTX) Q3 2024 Earnings: Revenue Hits $83.3M, EPS at $0.02, Surpassing Estimates - GuruFocus.com
HC Wainwright Increases TG Therapeutics (NASDAQ:TGTX) Price Target to $55.00 - MarketBeat
TG Therapeutics: Modest Q3 Sales Beat, Focus Shifts To Early 2025 Updates (NASDAQ:TGTX) - Seeking Alpha
TG Therapeutics (NASDAQ:TGTX) Price Target Raised to $22.00 at The Goldman Sachs Group - MarketBeat
TG Therapeutics (NASDAQ:TGTX) Announces Earnings Results - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q3 2024 Earnings Call Transcript - Insider Monkey
TG Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Rec - GuruFocus.com
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
TG Therapeutics Inc (TGTX) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
Earnings call: TG Therapeutics reports robust growth for BRIUMVI - Investing.com
TG Therapeutics: Q3 Earnings Snapshot - Darien Times
Earnings call: TG Therapeutics reports robust growth for BRIUMVI By Investing.com - Investing.com UK
TG Therapeutics Posts Strong Q3 Briumvi Revenue, Here’s Why Shares Fell - Seeking Alpha
TG Therapeutics (TGTX) Lags Q3 Earnings Estimates - MSN
(TGTX) Trading Advice - Stock Traders Daily
FUJIFILM Diosynth Biotechnologies To Manufacture TG Therapeutics' MS Drug - Contract Pharma
TG Therapeutics (NASDAQ:TGTX) Shares Gap DownHere's What Happened - MarketBeat
Morning Brew: Nvidia Joins Dow, Fed Rate Cut Looms, and TG Thera - GuruFocus.com
FUJIFILM Diosynth Biotechnologies Signs Manufacturing Supply Agreement with TG Therapeutics - The Manila Times
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance - The Manila Times
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Holdings Increased by Raymond James & Associates - Defense World
TG Therapeutics Reports Third Quarter 2024 Financial - GlobeNewswire
TG Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Bought by Raymond James & Associates - MarketBeat
State of Alaska Department of Revenue Acquires Shares of 76,130 TG Therapeutics, Inc. (NASDAQ:TGTX) - MarketBeat
TG테라퓨틱스사 (TGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
0.16%
자본화:
|
볼륨(24시간):